Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Faster global financial news!
Simcere Pharmaceutical: Net profit in 2025 is expected to increase by approximately 80.1% to 93.9% year-over-year
25/02/2026 04:19
Complaint Report
Complaint Report
Simcere Pharmaceutical (02096.HK) announced that, The Group expects to record revenue of approximately RMB7.7 billion to RMB7.8 billion for the fiscal year 2025, representing an increase of approximately 16.0% to 17.6% compared to the revenue of approximately RMB6.635 billion for the year ended December 31, 2024. The Group is expected to record profit attributable to equity holders of the Company of approximately RMB 1.3 billion to RMB 1.4 billion for the fiscal year 2025, representing an increase of approximately 80.1% to 93.9% compared to the restated profit attributable to equity holders of the Company of approximately RMB 722 million for the fiscal year 2024.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
Scan to Download App
